Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Schizophrenia Research|April 15, 2008
Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosisIgnacio Mata, Rocio Perez-Iglesias, Jose Maria Pelayo-Teran, et al.
The Journal of Clinical Psychiatry|December 7, 2007
A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidoneRocio Perez-Iglesias, Benedicto Crespo-Facorro, Jose Antonio Amado, et al.
BMJ Open|November 28, 2024
A mindfulness-based, cognitive, social, digital relapse-prevention intervention for youth with depression in Australia: study protocol for a randomised controlled trial of ReboundShaminka N Mangelsdorf, Daniela Cagliarini, Yong Yi Lee, et al.
Schizophrenia Bulletin|June 1, 2023
The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services: Results From the Horyzons Randomized Controlled TrialLidia Engel, Mario Alvarez-Jimenez, Daniela Cagliarini, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 18, 2021
The Horyzons project: a randomized controlled trial of a novel online social therapy to maintain treatment effects from specialist first-episode psychosis servicesMario Alvarez-Jimenez, Peter Koval, Lianne Schmaal, et al.
BMJ Open|December 25, 2025
Can a digital intervention 'Momentum' improve social functioning and transdiagnostic symptoms for Australian youth at ultrahigh risk for psychosis? Protocol for a superiority randomised controlled trial comparing treatment as usual with and without MomentumShaminka N Mangelsdorf, Daniela Cagliarini, Barnaby Nelson, et al.
BMJ Open|February 21, 2019
HORYZONS trial: protocol for a randomised controlled trial of a moderated online social therapy to maintain treatment effects from first-episode psychosis servicesMario Alvarez-Jimenez, Sarah Bendall, Peter Koval, et al.
Pageof 1